Amniocentesis is a diagnostic test that analyzes a small sample of amniotic fluid to detect chromosomal abnormalities, genetic disorders, neural tube defects, and fetal infections. Unlike screening tests that estimate risk, amniocentesis provides a definitive yes-or-no answer for most conditions it checks. It’s typically offered from 15 weeks of pregnancy onward and is one of the most accurate prenatal tests available.
Chromosomal Abnormalities
The most common reason for amniocentesis is to check for problems with the baby’s chromosomes. The fluid contains cells shed by the baby, and lab technicians can examine those cells to count and inspect each chromosome. This detects conditions caused by extra, missing, or structurally abnormal chromosomes, including Down syndrome (an extra copy of chromosome 21), Edwards syndrome (extra chromosome 18), and Patau syndrome (extra chromosome 13). It also identifies sex chromosome differences like Turner syndrome.
The test catches far more than the handful of conditions that blood-based screening looks for. A study in the Annals of Translational Medicine found that noninvasive prenatal testing (NIPT), the blood draw offered earlier in pregnancy, missed 30% of the chromosomal abnormalities that amniocentesis detected. NIPT is excellent at flagging the most common trisomies, catching about 99% of Down syndrome cases and 98.5% of Edwards syndrome cases, but it’s a screening tool that estimates probability. Amniocentesis confirms or rules out the diagnosis.
Single-Gene Disorders
When both parents carry a gene for a specific inherited condition, amniocentesis can determine whether the baby has inherited it. This includes conditions like cystic fibrosis, sickle cell disease, and Tay-Sachs disease. Testing for these usually happens when family history or carrier screening has already identified a known risk, since the lab needs to know which gene to look for. The fetal cells from the amniotic fluid provide enough DNA for targeted genetic analysis.
Neural Tube Defects
Amniocentesis measures levels of a protein called alpha-fetoprotein (AFP) in the amniotic fluid. This protein is produced mainly by the baby’s developing liver, and some of it normally passes into the surrounding fluid. When the baby has a neural tube defect, significantly more AFP leaks out, raising the levels well above normal.
Higher AFP levels signal an increased risk of two major conditions. Spina bifida occurs when the bones of the baby’s spine don’t fully close around the spinal cord, often causing nerve and spinal cord damage. Anencephaly is a more severe condition where most of the brain and skull fail to develop. Measuring AFP directly in the amniotic fluid is more precise than the blood test offered during routine screening, which only measures AFP that has crossed into the mother’s bloodstream.
Fetal Infections
Amniocentesis can detect whether certain infections have crossed the placenta and reached the baby. If a pregnant person is exposed to infections like toxoplasmosis or cytomegalovirus (CMV), the amniotic fluid can be tested to confirm or rule out transmission to the baby. This helps guide decisions about treatment and monitoring for the rest of the pregnancy. It’s not a routine use of amniocentesis, but it becomes important when there’s a specific exposure or concern.
Fetal Lung Maturity
Later in pregnancy, amniocentesis serves a completely different purpose: checking whether the baby’s lungs are mature enough for delivery. This matters when early delivery is being considered for medical reasons.
The test measures the ratio of two substances in the amniotic fluid that reflect how much surfactant the baby’s lungs are producing. Surfactant is the coating that keeps the tiny air sacs in the lungs from collapsing. A ratio of 2.0 or higher is about 98% predictive of lung maturity. In a typical pregnancy, this ratio rises naturally from below 0.5 at 20 weeks to 2.0 or above by around 35 to 36 weeks. The presence of a specific fat called phosphatidylglycerol provides additional confirmation that the lungs are ready.
How the Test Works
During amniocentesis, a thin needle is guided by ultrasound through the abdomen and into the amniotic sac. About 20 milliliters of fluid, roughly four teaspoons, is withdrawn. The procedure itself takes only a few minutes. It should not be performed before 15 weeks of pregnancy, as earlier testing carries higher risks and lower accuracy.
For Rh-negative individuals (those with a blood type that lacks the Rh factor), the procedure can occasionally cause the baby’s blood cells to enter the parent’s bloodstream. To prevent the immune system from producing antibodies that could harm the baby, an injection of Rh immune globulin is given after the procedure.
How Long Results Take
Results arrive in two waves. A rapid preliminary test called FISH (fluorescence in situ hybridization) checks for the most common chromosomal conditions, specifically chromosomes 13, 18, 21, X, and Y, and delivers results in one to two working days. The full karyotype, which examines every chromosome in detail for structural problems and rarer abnormalities, requires the cells to be grown in culture and takes 10 to 14 days.
If additional genetic testing like microarray analysis is ordered, those results can also take up to two weeks. Your provider will typically share the rapid FISH results first, which answers the most pressing questions for most families, with the complete picture following a couple of weeks later.
Why It’s Offered After Screening
Most people encounter amniocentesis as a follow-up to an earlier screening result. If a first-trimester blood test, NIPT, or ultrasound flags an elevated risk for a chromosomal condition, amniocentesis provides the definitive answer. It’s also offered when a parent is 35 or older at delivery, when there’s a family history of a genetic condition, or when a previous pregnancy was affected.
The key distinction is between screening and diagnosis. Screening tests like NIPT are very good at identifying high-risk pregnancies, but they produce false positives and can’t detect the full range of chromosomal problems. Amniocentesis, because it works directly with the baby’s own cells, provides a diagnosis rather than a probability. For the conditions it tests, accuracy is near 100%.